20
Granules India Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for World-class facilities for APIs, PFIs & FDFs, Serving customers in over 75+ countries.
One of their significant offerings is Telmisartan, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2011-355 - Rev 01
This Chemical Type CEP, issued on January 29, 2015, remains in force until January 03, 2018, ensuring its reliability within the pharmaceutical industry.
Substance Number 2154 associated with this CEP further emphasizes